Cor Vasa 2012, 54(5-6):e202-e208 | DOI: 10.1016/j.crvasa.2012.05.012

Renal denervation in the treatment of resistant arterial hypertension and other perspectives

Martin Poloczeka, Petra Vysočanováa, Roman Miklíka, Igor Nyklb, Petr Kalaa
a Interní kardiologická klinika, Lékařská fakulta Masarykovy univerzity a Fakultní nemocnice Brno, Brno, Česká republika
b Oddělení kardiologie, Kardiocentrum, Nemocnice Podlesí, a. s., Třinec, Česká republika

Keywords: Renal denervation; Resistant hypertension; Sympathetic nervous system

Received: May 9, 2012; Revised: May 25, 2012; Accepted: May 26, 2012; Published: May 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Poloczek M, Vysočanová P, Miklík R, Nykl I, Kala P. Renal denervation in the treatment of resistant arterial hypertension and other perspectives. Cor Vasa. 2012;54(5-6):e202-208. doi: 10.1016/j.crvasa.2012.05.012.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Cífková R, Bruthans J, Adámková V, et al. Prevalence základních kardiovaskulárních rizikových faktorů v české populaci v letech 2006-2009. Studie Czech post-MONICA. Cor Vasa 2011;53:220-9. Go to original source...
    2. Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007;28:1462-1536. Go to original source... Go to PubMed...
    3. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003;290:199-206. Go to original source... Go to PubMed...
    4. Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation 2008;117:e510-26. Go to original source... Go to PubMed...
    5. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288:2981-97. Go to original source... Go to PubMed...
    6. Kaplan NM. Resistant hypertension. J Hypertens 2005;23:1441-4. Go to original source... Go to PubMed...
    7. Sarafidis PA, Bakris GL. Resistant hypertension: an overview of evaluation and treatment. J Am Coll Cardiol 2008;52:1749-57. Go to original source... Go to PubMed...
    8. Pikus T, Widimský J Jr, Rosa J, Štrauch B, Petrák O, Holaj R. Prevalence a klinická charakteristika rezistentní hypertenze ve specializovaném centru. Cor Vasa 2007;49:351-4. Go to original source...
    9. Grassi G, Cattaneo BM, Seravalle G, Lanfranchi A, Mancia G. Baroreflex control of sympathetic nerve activity in essential and secondary hypertension. Hypertension 1998;31:68-72. Go to original source... Go to PubMed...
    10. Mancia G, Grassi G, Giannattasio C, Seravalle G. Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. Hypertension 1999;34:724-8. Go to original source... Go to PubMed...
    11. Esler M, Lambert G, Jennings G. Regional norepinephrine turnover in human hypertension. Clin Exp Hypertens A 1989; 11 Suppl 1:75-89. Go to original source... Go to PubMed...
    12. Peet MM, Woods WW, Braden S. The Surgical Treatment for Hypertension: Results in Three Hundred and Fifty Consecutive Cases Treated by Bilateral Supradiaphragmatic Splanchnicectomy and Lower Dorsal Sympathetic Ganglionectomy. JAMA 1940;115:1875-8. Go to original source...
    13. Goldsmith SR, Sobotka PA, Bart BA. The sympathorenal axis in hypertension and heart failure. J Card Fail 2010;16:369-73. Go to original source... Go to PubMed...
    14. Converse RL, Jacobsen TN, Toto RD, et al. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 1992;327:1912-8. Go to original source... Go to PubMed...
    15. Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD. Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med 2009;361:932-4. Go to original source... Go to PubMed...
    16. Rippy M, Zarins D, Barman N, Wu A, Duncan K, Zarins C. Catheter-based renal sympathetic denervation: chronic preclinical evidence for renal artery safety. Clin Res Cardiol 2011;100:1095-101. Go to original source... Go to PubMed...
    17. http://www.recormedical.com
    18. Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 2011;373:1275-81. Go to original source... Go to PubMed...
    19. Symplicity HTN-1 Investigators. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension 2011;57:911-7. Go to original source... Go to PubMed...
    20. Symplicity HTN-2 Investigators. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 2010;376:1903-9. Go to original source... Go to PubMed...
    21. http://clinicaltrials.gov/ct2/show/study/NCT01418261
    22. DiBona GF. Physiology in perspective: The Wisdom of the Body. Neural control of the kidney. Am J Physiol Regul Integr Comp Physiol 2005;289:R633-41. Go to original source... Go to PubMed...
    23. Mancia G, Bousquet P, Elghozi JL, et al. The sympathetic nervous system and the metabolic syndrome. J Hypertens 2007;25:909-20. Go to original source... Go to PubMed...
    24. Mahfoud F, Schlaich M, Kindermann I, et al. Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study. Circulation 2011;123:1940-6. Go to original source... Go to PubMed...
    25. Witkowski A, Prejbisz A, Florczak E, et al. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea. Hypertension 2011;58:559-65. Go to original source... Go to PubMed...
    26. Friedman O, Bradley TD, Chan CT, Parkes R, Logan AG. Relationship between overnight rostral fluid shift and obstructive sleep apnea in drug-resistant hypertension. Hypertension 2010;56:1077-82. Go to original source... Go to PubMed...
    27. Hasking GJ, Esler MD, Jennings GL, Burton D, Johns JA, Korner PI. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 1986;73:615-21. Go to original source... Go to PubMed...
    28. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med 1987;316:1429-35. Go to original source... Go to PubMed...
    29. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med 1991;325:293-302. Go to original source... Go to PubMed...
    30. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999;353:9-13. Go to original source...
    31. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-7. Go to original source...
    32. Cohn JN, Tognoni G; Valsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 2001;345:1667-75. Go to original source... Go to PubMed...
    33. McMurray JJ, Ostergren J, Swedberg K, et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial. Lancet 2003;362:767-71. Go to original source... Go to PubMed...
    34. Clayton SC, Haack KK, Zucker IH. Renal denervation modulates angiotensin receptor expression in the renal cortex of rabbits with chronic heart failure. Am J Physiol Renal Physiol 2011;300:F31-9. Go to original source... Go to PubMed...
    35. Brandt MC, Mahfoud F, Reda S, et al. Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. J Am Coll Cardiol 2012;59:901-9. Go to original source... Go to PubMed...
    36. Ukena C, Bauer A, Mahfoud F, et al. Renal sympathetic denervation for treatment of electrical storm: first-in-man experience. Clin Res Cardiol 2012;101:63-7. Go to original source... Go to PubMed...
    37. Schmieder RE, Redon J, Grassi G, et al. ESH position paper: renal denervation - an interventional therapy of resistant hypertension. J Hypertens 2012;30:837-41. Go to original source...
    38. Widimský P, Filipovský J, Widimský J, Branny M, Monhart V, Táborský M. Expert consensus statement of the Czech Society of Cardiology and the Czech Society of Hypertension on catheter-based sympathetic renal denervation procedures (RDN) in the Czech Republic. Cor Vasa 2012;54:e108-12. Go to original source...

    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes